SEC Form 4 · accession 0001127602-15-023011
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon P Stonehouse
Officer — President & CEO · Director
Period of report
Jul 15, 2015
Accepted (ET)
Jul 17, 2015 · 9:45 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 15, 2015 | M | 33,868 | $11.81 | A | 684,737 | D | |
| Common Stock | Jul 15, 2015 | F | 25,526 | $15.67 | D | 659,211 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Emp. Stock Option (Right to Buy) | $11.81 | Jul 15, 2015 | M | 33,868 | D | Jan 5, 2008 | Jan 5, 2017 | Common Stock | 33,868 | 416,132 | D |